Amneal Pharmaceuticals (AMRX) Current Leases (2017 - 2026)

Amneal Pharmaceuticals' Current Leases history runs 10 years deep, the most recent figure standing at $8.9 million for Q1 2026.

• In Q1 2026, Current Leases rose 168.82% year-over-year to $8.9 million; the TTM figure through Mar 2026 stood at $8.9 million (up 168.82% YoY), while the FY2025 annual figure was $8.7 million, up 169.95% from the prior year.
• Current Leases was $8.9 million for Q1 2026 at Amneal Pharmaceuticals, up from $8.7 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $9.8 million in Q3 2023 to a low of $2.8 million in Q3 2022.
• Historically, Current Leases has averaged $4.9 million across 5 years, with a median of $3.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Current Leases slumped 69.4% in 2022, then jumped 249.8% in 2023.
• A 5-year view of Current Leases shows it stood at $3.5 million in 2022, then dropped by 19.01% to $2.8 million in 2023, then rose by 13.66% to $3.2 million in 2024, then jumped by 169.95% to $8.7 million in 2025, then rose by 2.93% to $8.9 million in 2026.
• The last three Current Leases figures came in at $8.9 million (Q1 2026), $8.7 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.